Systematic review of epidemiological studies of exposure to tritium

Tritium (3H) is a radioactive isotope of hydrogen. A number of factors combine to create a good deal of interest in the risks arising from exposure to tritium of both workers and members of the public. Tritium is ubiquitous in environmental and biological systems and is very mobile due to its occurrence as tritiated water. In this paper we systematically review epidemiological data relating to tritium exposure with a view to assessing the risk of such exposure using those studies that are potentially informative. The usefulness of the available studies of cancer and other adverse health effects in workforces and members of the general public is often impaired by a lack of tritium-specific dose data, low doses and small numbers of cases. A number of workforce studies have been identified in which tritium-specific individual doses have been estimated, although none of them, as presently reported, enable reliable inferences to be made on risks associated with exposure to tritium. In general, the available epidemiological studies on the offspring of radiation workers or on pregnancy outcome in areas subject to releases of tritium do not contain enough detail to estimate risks from tritium exposure. Although the studies presently reported are uninformative on risks from tritium, a number of the occupationally exposed cohorts would be potentially informative, particularly if data were suitably combined.

[1]  W Burkart,et al.  Leukaemia in the vicinity of two tritium-releasing nuclear facilities: a comparison of the Kruemmel Site, Germany, and the Savannah River Site, South Carolina, USA. , 1999, Journal of radiological protection : official journal of the Society for Radiological Protection.

[2]  K. Binks,et al.  The mortality and cancer morbidity experience of employees at the Chapelcross plant of British Nuclear Fuels plc, 1955-95. , 2001, Journal of radiological protection : official journal of the Society for Radiological Protection.

[3]  M. Wrenn Tritium in the Environment. , 1980 .

[4]  J. Cameron The Relative Biological Effectiveness of Radiations of Different Quality, NCRP Report 104 , 1992 .

[5]  K. Binks,et al.  Mortality and cancer morbidity experience of female workers at the British Nuclear Fuels Sellafield plant, 1946-1998. , 2003, American journal of industrial medicine.

[6]  P. Band,et al.  First analysis of mortality and occupational radiation exposure based on the National Dose Registry of Canada. , 1998, American journal of epidemiology.

[7]  岩崎 民子 SOURCES AND EFFECTS OF IONIZING RADIATION : United Nations Scientific Committee on the Effects of Atomic Radiation UNSCEAR 2000 Report to the General Assembly, with Scientific Annexes , 2002 .

[8]  Quantitative Estimation and Prediction of Human Cancer Risks , 2000 .

[9]  H. Stockwell,et al.  Descriptive study of deaths from cancer associated with residential proximity to the site of underground nuclear detonations. , 1998, Archives of environmental health.

[10]  D. Jackson,et al.  Reconstruction of discharges and environmental doses from a former tritium facility at BNFL Capenhurst , 1997 .

[11]  R. Doll,et al.  Cancer mortality following X‐ray treatment for ankylosing spondylitis , 1994, International journal of cancer.

[12]  V. Beral,et al.  Case-control study of prostatic cancer in employees of the United Kingdom Atomic Energy Authority. , 1993, BMJ.

[13]  Charles Mw,et al.  Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. , 2003 .

[14]  T. Fearn,et al.  Leukemia mortality after X-ray treatment for ankylosing spondylitis. , 1995, Radiation research.

[15]  B. Lambert Invited editorial: Welsh tritium. , 2001, Journal of radiological protection : official journal of the Society for Radiological Protection.

[16]  V. Michalik,et al.  Theoretical estimation of quality factor for tritium. , 1992, Health physics.

[17]  K. Binks,et al.  The mortality and cancer morbidity experience of workers at the Capenhurst uranium enrichment facility 1946-95 , 2000, Journal of radiological protection : official journal of the Society for Radiological Protection.

[18]  G. Howe,et al.  Analysis of Mortality among Canadian Nuclear Power Industry Workers after Chronic Low-Dose Exposure to Ionizing Radiation , 2004, Radiation research.

[19]  M. Little,et al.  Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors. , 1999, Radiation research.

[20]  E. Aileen Clarke,et al.  Childhood leukemia in the vicinity of Canadian nuclear facilities , 2004, Cancer Causes & Control.

[21]  V. Beral,et al.  Cancer mortality in relation to monitoring for radionuclide exposure in three UK nuclear industry workforces. , 1998, British Journal of Cancer.

[22]  G. Howe Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the Atomic Bomb survivors study. , 1995, Radiation research.

[23]  A. Miller,et al.  Risk of congenital anomalies in children of parents occupationally exposed to low level ionising radiation. , 1997, Occupational and environmental medicine.

[24]  P. Smith,et al.  CALENDAR , 1984, British Journal of Cancer.

[25]  E A Clarke,et al.  Paternal radiation exposure and leukaemia in offspring: the Ontario case-control study. , 1993, BMJ.

[26]  P Fraser,et al.  Radiation dose and second cancer risk in patients treated for cancer of the cervix. , 1988, Radiation research.

[27]  Steve Wing,et al.  Leukemia mortality among workers at the Savannah River Site. , 2007, American journal of epidemiology.

[28]  L. Feinendegen,et al.  Microdosimetry of tritium. , 1993, Health physics.

[29]  C. Wall,et al.  Second Cancers Following Radiation Treatment for Cervical Cancer. An International Collaboration Among Cancer Registries , 1985 .

[30]  Jack Valentin,et al.  Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (wR) , 2003 .

[31]  W. A. Jennings Towards the ICRP's new recommendations--problems in dosimetry. , 2001, Journal of radiological protection : official journal of the Society for Radiological Protection.

[32]  J. Harrison,et al.  Doses from the consumption of Cardiff Bay flounder containing organically bound tritium , 2005, Journal of radiological protection : official journal of the Society for Radiological Protection.

[33]  V. Beral,et al.  Mortality of employees of the United Kingdom Atomic Energy Authority, 1946-1979. , 1985, British medical journal.

[34]  M. Little,et al.  Systematic review of experimental studies on the relative biological effectiveness of tritium , 2008, Radiation and environmental biophysics.

[35]  G R Howe,et al.  Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. , 1995, Radiation research.

[36]  A. Carsten Tritium in the Environment , 1979 .

[37]  Icrp Radionuclide Transformations : Energy and Intensity of Emissions. , 1983 .

[38]  V. Beral,et al.  Mortality of employees of the Atomic Weapons Establishment, 1951-82. , 1988, BMJ.

[39]  C C Lushbaugh,et al.  Mortality among workers at a nuclear fuels production facility. , 1988, American journal of industrial medicine.

[40]  Icrp Recommendations of the International Commission on Radiological Protection Publication 60 , 1991 .

[41]  T. Fell,et al.  Second analysis of the national registry for radiation workers: Occupational exposure to ionising radiation and mortality , 1992 .

[42]  C R Muirhead,et al.  Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis. , 1999, Radiation research.

[43]  Yukiko Shimizu,et al.  Effect of Recent Changes in Atomic Bomb Survivor Dosimetry on Cancer Mortality Risk Estimates , 2004, Radiation research.

[44]  Robert D. Daniels,et al.  Risk of Chronic Myeloid and Acute Leukemia Mortality after Exposure to Ionizing Radiation among Workers at Four U.S. Nuclear Weapons Facilities and a Nuclear Naval Shipyard , 2007, Radiation research.

[45]  E. G. Letourneau,et al.  First analysis of cancer incidence and occupational radiation exposure based on the National Dose Registry of Canada. , 2001, American journal of epidemiology.

[46]  Icrp Age-dependent doses to members of the public from intake of radionuclides: Part 4 Inhalation dose coefficients , 1995, Annals of the ICRP.

[47]  D. V. Law,et al.  A decline in mortality from prostate cancer in the UK Atomic Energy Authority workforce , 2007, Journal of radiological protection : official journal of the Society for Radiological Protection.

[48]  D. Mccubbin,et al.  An overview of tritium behaviour in the Severn Estuary (UK). , 2001, Journal of radiological protection : official journal of the Society for Radiological Protection.

[49]  D. V. Law,et al.  Mortality of employees of the United Kingdom Atomic Energy Authority, 1946–97 , 1985, Occupational and Environmental Medicine.